NMN emerges as a protective agent against neuronal damage caused by hypoglycemia, a serious complication of insulin therapy in diabetes. The study conducted by Sakurai et al. reveals that administering NMN can counteract the neuronal damage and cognitive impairment typically induced by drops in blood glucose levels. The researchers observed reduced neuronal death by supplementing …
More
